Intuitive Surgical, Inc.

Intuitive Surgical develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and globally. Its main product is the da Vinci Surgical System, which allows surgeons to perform procedures using a minimally invasive approach. The company also offers the Ion endoluminal system, which extends its offerings beyond surgery into diagnostic endoluminal procedures, enabling minimally invasive biopsies in the lung. Additionally, Intuitive provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci systems, along with progressive learning pathways, customer service and support, installation, repair, maintenance, 24/7 technical support, proactive system health monitoring, and integrated digital capabilities.

Intuitive Surgical is listed on the Nasdaq Global Select Market (NasdaqGS) under the ticker symbol ISRG. The company trades in US dollars (USD), as it is headquartered in the United States and its primary listing is on a US exchange. The currency is important for investors to consider when evaluating financial performance and making investment decisions, as all financial reports and stock prices are denominated in USD.

Intuitive Surgical operates in the Healthcare sector, specifically within the Medical Instruments & Supplies industry. This classification reflects the company's focus on developing and manufacturing advanced medical devices, particularly robotic surgical systems and related instruments. The Medical Instruments & Supplies industry includes companies that produce a wide range of medical equipment, from surgical instruments to diagnostic devices, and Intuitive is a leading innovator in robotic-assisted surgery.

Intuitive Surgical is headquartered in Sunnyvale, California, United States. The company was incorporated in 1995 and serves markets both in the United States and globally. Its products, including the da Vinci Surgical System and Ion endoluminal system, are used by physicians and healthcare providers worldwide to enhance minimally invasive care. The company sells its products through direct sales organizations, including capital and clinical sales teams, and provides extensive customer support services such as installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring.

Intuitive Surgical generates revenue through the sale of its robotic surgical systems, instruments, and accessories, as well as through services and support. The company's primary product is the da Vinci Surgical System, which is sold to hospitals and surgical centers. Additionally, Intuitive sells a suite of stapling, energy, and core instrumentation for its multi-port da Vinci systems, and the Ion endoluminal system for lung biopsies. Recurring revenue comes from the sale of instruments and accessories used with its systems, as well as from service contracts that include installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring. The company also offers progressive learning pathways and integrated digital capabilities to support its customers.